-
-
-
-
-
-
-
UBS Reiterates Buy Rating on Johnson & Johnson (JNJ)
-
-
-
-
-
-
-
Intuitive Surgical: Oppenheimer now bullish, sees competition being "crowded out"
-
-
-
-
-
-
-
Johnson & Johnson agrees to $5.5B settlement of ovarian talc claims
-
-
-
-
-
-
-
Johnson & Johnson (JNJ) call put ratio 1.6 calls to 1 put into quarter results
-
-
-
-
-
-
-
Johnson & Johnson (JNJ) PT Raised to $270 at Guggenheim
-
-
-
-
-
-
-
Johnson & Johnson faces $32 million verdict in Los Angeles asbestos case
-
-
-
-
-
-
-
Leerink Partners Upgrades Johnson & Johnson (JNJ) to Outperform
-
474,540 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


